Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.32 |
| ▸ | PTAFR | P25105 | 1/20 | 0.32 |
| ▸ | HTR1D | P28221 | 1/20 | 0.32 |
| ▸ | HTR2C | P28335 | 1/20 | 0.32 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.32 |
| ▸ | DRD3 | P35462 | 1/20 | 0.32 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.31 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.31 |
| ▸ | NR5A2 | O00482 | 1/20 | 0.31 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL541550 | 0.93 | TSHR (0.38) | TSHRTHRB | |
| SCHEMBL2037326 | 0.92 | TSHR (0.43) | TSHRTHRBMAPTADRA1DPTAFR | |
| SCHEMBL2037549 | 0.91 | TSHR (0.44) | TSHRTHRBSMN1; SMN2 | |
| SCHEMBL541535 | 0.88 | THRB (0.38) | TSHRTHRB | |
| SCHEMBL2041337 | 0.84 | TSHR (0.39) | TSHRTHRB | |
| SCHEMBL28874092 | 0.84 | TSHR (0.46) | TSHRTHRB | |
| SCHEMBL28637235 | 0.83 | TSHR (0.40) | TSHRTHRBSMN1; SMN2 | |
| SCHEMBL6851650 | 0.83 | TSHR (0.38) | TSHRTHRB | |
| SCHEMBL28874094 | 0.82 | TSHR (0.43) | TSHRTHRB | |
| SCHEMBL2034320 | 0.80 | TSHR (0.47) | TSHRTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240189121-A1 | ANTI-THROMBOGENIC MEDICAL DEVICES AND METHODS | COVIDIEN LP | 2024-06-13 | — | — | US | claimed |
| EP-3666299-B1 | ANTI-THROMBOGENIC MEDICAL DEVICES AND METHODS | COVIDIEN LP (US) | 2024-05-15 | — | — | EP | claimed |
| US-11903850-B2 | Anti-thrombogenic medical devices and methods | COVIDIEN LP (US) | 2024-02-20 | — | — | US | claimed |
| US-20230036800-A1 | ANTI-THROMBOGENIC MEDICAL DEVICES AND METHODS | COVIDIEN LP | 2023-02-02 | — | — | US | claimed |
| US-11406514-B2 | Anti-thrombogenic medical devices and methods | COVIDIEN LP (US) | 2022-08-09 | — | — | US | claimed |
| US-20220227954-A1 | POLYMERIC SURFACE HAVING REDUCED BIOMOLECULE ADHESION TO THERMOPLASTIC ARTICLES OF SUCH SUBSTRATE | OAKTREE FUND ADMINISTRATION, LLC | 2022-07-21 | — | — | US | claimed |
| US-11369497-B2 | Anti-thrombogenic medical devices and methods | COVIDIEN LP (US) | 2022-06-28 | — | — | US | claimed |
| EP-3862384-A2 | POLYMERIC SUBSTRATE WITH A SURFACE HAVING REDUCED BIOMOLECULE ADHESION, AND THERMOPLASTIC ARTICLES OF SUCH SUBSTRATE | SiO2 Medical Products, Inc. (US) | 2021-08-11 | — | — | EP | claimed |
| US-20210068991-A1 | ANTI-THROMBOGENIC MEDICAL DEVICES AND METHODS | COVIDIEN LP | 2021-03-11 | — | — | US | claimed |
| US-10835393-B2 | Anti-thrombogenic medical devices and methods | COVIDIEN LP (US) | 2020-11-17 | — | — | US | claimed |
| US-10137012-B2 | — | — | 2018-11-27 | — | — | US | claimed |
| EP-3400973-A1 | METHOD OF MANUFACTURING ANTI-THROMBOGENIC MEDICAL DEVICES | Covidien LP (US) | 2018-11-14 | — | — | EP | claimed |
| EP-2875833-B1 | Anti-thrombogenic medical devices and methods | COVIDIEN LP (US) | 2018-08-08 | — | — | EP | claimed |
| US-20170232156-A1 | ANTI-THROMBOGENIC MEDICAL DEVICES AND METHODS | COVIDIEN LP | 2017-08-17 | — | — | US | claimed |
| US-9668890-B2 | Anti-thrombogenic medical devices and methods | COVIDIEN LP (US) | 2017-06-06 | — | — | US | claimed |
| WO-2015077081-A1 | ANTI-THROMBOGENIC MEDICAL DEVICES AND METHODS | COVIDIEN LP (US) | 2015-05-28 | — | — | WO | claimed |
| US-20150148882-A1 | ANTI-THROMBOGENIC MEDICAL DEVICES AND METHODS | COVIDIEN LP | 2015-05-28 | — | — | US | claimed |
| EP-2875833-A1 | Anti-thrombogenic medical devices and methods | Covidien LP (US) | 2015-05-27 | — | — | EP | claimed |
| US-20150140344-A1 | COATED MEDICAL DEVICES | COVIDIEN LP | 2015-05-21 | — | — | US | claimed |
| US-20100094339-A1 | COATING COMPOSITIONS | COVIDIEN LP | 2010-04-15 | — | — | US | claimed |